-+ 0.00%
-+ 0.00%
-+ 0.00%

4D Molecular Therapeutics secures credit facility up to $200 million from Hercules Capital

PUBT·06/29/2026 12:02:21
Listen to the news
4D Molecular Therapeutics secures credit facility up to $200 million from Hercules Capital
  • 4D Molecular Therapeutics entered a strategic credit facility with Hercules Capital for up to $200 million.
  • $20 million was drawn at closing.
  • Another $30 million is available at the company’s option through June 15, 2027.
  • $100 million becomes available upon achieving specified milestones; the remaining $50 million requires final lender approval.
  • Cash, cash equivalents, and marketable securities totaled $458 million as of March 31, 2026, excluding the new facility.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. 4D Molecular Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606290800PRIMZONEFULLFEED9753339) on June 29, 2026, and is solely responsible for the information contained therein.